GAUMONT SA (GAM.PA) Fundamental Analysis & Valuation

EPA:GAM • FR0000034894

Current stock price

101 EUR
0 (0%)
Last:

This GAM.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. GAM.PA Profitability Analysis

1.1 Basic Checks

  • In the past year GAM has reported negative net income.
  • GAM had a positive operating cash flow in the past year.
  • In the past 5 years GAM reported 4 times negative net income.
  • In the past 5 years GAM always reported a positive cash flow from operatings.
GAM.PA Yearly Net Income VS EBIT VS OCF VS FCFGAM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -3.32%, GAM is in line with its industry, outperforming 45.45% of the companies in the same industry.
  • With a Return On Equity value of -7.09%, GAM perfoms like the industry average, outperforming 52.27% of the companies in the same industry.
Industry RankSector Rank
ROA -3.32%
ROE -7.09%
ROIC N/A
ROA(3y)-1.86%
ROA(5y)-1.74%
ROE(3y)-4.1%
ROE(5y)-3.94%
ROIC(3y)N/A
ROIC(5y)N/A
GAM.PA Yearly ROA, ROE, ROICGAM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

1.3 Margins

  • With an excellent Gross Margin value of 91.02%, GAM belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GAM has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for GAM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 91.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.33%
GAM.PA Yearly Profit, Operating, Gross MarginsGAM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. GAM.PA Health Analysis

2.1 Basic Checks

  • GAM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • GAM has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for GAM remains at a similar level compared to 5 years ago.
  • GAM has a worse debt/assets ratio than last year.
GAM.PA Yearly Shares OutstandingGAM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
GAM.PA Yearly Total Debt VS Total AssetsGAM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • GAM has an Altman-Z score of 1.59. This is a bad value and indicates that GAM is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.59, GAM is in the better half of the industry, outperforming 70.45% of the companies in the same industry.
  • GAM has a debt to FCF ratio of 3.31. This is a good value and a sign of high solvency as GAM would need 3.31 years to pay back of all of its debts.
  • GAM has a Debt to FCF ratio of 3.31. This is in the better half of the industry: GAM outperforms 61.36% of its industry peers.
  • A Debt/Equity ratio of 0.10 indicates that GAM is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.10, GAM belongs to the top of the industry, outperforming 86.36% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 3.31
Altman-Z 1.59
ROIC/WACCN/A
WACC8.01%
GAM.PA Yearly LT Debt VS Equity VS FCFGAM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • GAM has a Current Ratio of 0.93. This is a bad value and indicates that GAM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.93, GAM is in line with its industry, outperforming 59.09% of the companies in the same industry.
  • GAM has a Quick Ratio of 0.93. This is a bad value and indicates that GAM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of GAM (0.93) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.93
GAM.PA Yearly Current Assets VS Current LiabilitesGAM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. GAM.PA Growth Analysis

3.1 Past

  • The earnings per share for GAM have decreased strongly by -53.92% in the last year.
  • GAM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.54%.
  • GAM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.68% yearly.
EPS 1Y (TTM)-53.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19436.14%
Revenue 1Y (TTM)-31.54%
Revenue growth 3Y-17.38%
Revenue growth 5Y-6.68%
Sales Q2Q%-31.83%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GAM.PA Yearly Revenue VS EstimatesGAM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

Find the best growth stocksShow best growing peers

1

4. GAM.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GAM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GAM.PA Price Earnings VS Forward Price EarningsGAM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • 70.45% of the companies in the same industry are more expensive than GAM, based on the Enterprise Value to EBITDA ratio.
  • GAM's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 54.31
EV/EBITDA 6.73
GAM.PA Per share dataGAM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GAM.PA Dividend Analysis

5.1 Amount

  • GAM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GAM.PA Fundamentals: All Metrics, Ratios and Statistics

GAUMONT SA

EPA:GAM (3/13/2026, 7:00:00 PM)

101

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)03-12
Earnings (Next)N/A
Inst Owners4.74%
Inst Owner ChangeN/A
Ins Owners89.79%
Ins Owner ChangeN/A
Market Cap315.12M
Revenue(TTM)120.12M
Net Income(TTM)-12.71M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.62
P/FCF 54.31
P/OCF 3.4
P/B 1.76
P/tB 7.51
EV/EBITDA 6.73
EPS(TTM)-4.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.86
FCFY1.84%
OCF(TTM)29.73
OCFY29.44%
SpS38.5
BVpS57.48
TBVpS13.45
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.32%
ROE -7.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 91.02%
FCFM 4.83%
ROA(3y)-1.86%
ROA(5y)-1.74%
ROE(3y)-4.1%
ROE(5y)-3.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.33%
F-Score3
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 3.31
Debt/EBITDA 0.45
Cap/Depr 168.48%
Cap/Sales 72.39%
Interest Coverage N/A
Cash Conversion 237.72%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.93
Altman-Z 1.59
F-Score3
WACC8.01%
ROIC/WACCN/A
Cap/Depr(3y)93.45%
Cap/Depr(5y)100.19%
Cap/Sales(3y)40.27%
Cap/Sales(5y)48.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19436.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.54%
Revenue growth 3Y-17.38%
Revenue growth 5Y-6.68%
Sales Q2Q%-31.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-384.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-67.19%
FCF growth 3Y-9.67%
FCF growth 5YN/A
OCF growth 1Y-3.39%
OCF growth 3Y-11.79%
OCF growth 5Y-4.74%

GAUMONT SA / GAM.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GAUMONT SA?

ChartMill assigns a fundamental rating of 2 / 10 to GAM.PA.


Can you provide the valuation status for GAUMONT SA?

ChartMill assigns a valuation rating of 1 / 10 to GAUMONT SA (GAM.PA). This can be considered as Overvalued.


Can you provide the profitability details for GAUMONT SA?

GAUMONT SA (GAM.PA) has a profitability rating of 3 / 10.


Can you provide the dividend sustainability for GAM stock?

The dividend rating of GAUMONT SA (GAM.PA) is 0 / 10 and the dividend payout ratio is 0%.